PROC - Wall Street Estimates - Procaps Group S.A. - IntrinsicAlpha

Procaps Group S.A. PROC

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - LU

$ 1.71

-1.16 %

$ 193 M

Market Cap

3.35

P/E

Price Target Average

--100.00%

Revenue Forecast Estimate

1595.45%

EBIT Estimate

1512.56%

Net Income Estimate

42.61%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Procaps Group S.A.

PROC has no price targets from Wall Street.

REVENUE FORECAST

Revenue Forecast Chart PROC

EBIT FORECAST

EBIT Forecast Chart PROC

NET INCOME FORECAST

Net Income Chart PROC